Effects of Ginkgo Biloba on Blood Biomarkers in Mild Cognitive Impairment

Summary

This study evaluates the effects of Ginkgo biloba on blood biomarkers related to Alzheimer's disease in patients with mild cognitive impairment. Participants will be randomly assigned to receive either Ginkgo biloba or a placebo for 6 months. Changes in blood biomarkers, including p-tau217 and neurofilament light (NfL), as well as cognitive function, will be assessed to determine whether Ginkgo biloba may influence disease-related biological processes.

Timeline

Start

2026-06

Primary completion

2028-12-31

Completion

2028-12-31

Drugs

Indications